Designing Antibodies with Code.
About Us
Antibodies are a $250B+ market powering therapies, diagnostics, and research — but the discovery process is broken. It’s slow (6–18 months), expensive (millions per candidate), and still relies heavily on animal models. Vici.bio is replacing lab-based antibody discovery with computation. We’ve built an end-to-end AI algorithm that designs antibodies digitally — cutting discovery time from months to hours and reducing cost by 99%. No cages. Just code.
Our in silico solution
We develop antibodies for...
Vici.bio focuses on non-clinical applications, we focus on industries with low regulatory hurdles.
Agriculture
Identify pathogens and pesticide residues.
Diagnostics
Tests for diseases and infections.
Bioprocessing
Detect and neutralise contaminants.
Food Industry
Identify allergens in processed foods.
Environment
Identify bacteria, viruses, or toxins.
Cosmetics
Verify products are free from fungi.
And various more...